Page 20 - Revista SPORL - Vol 45. Nº2

JOSÉ CARLOS NEVES, JORGE MIGUÉIS, MÁRIO cºu; ANA CLETO, MARGARIDA AMORIM, SOFIA PAIVA,
CARLA GAPO, VERA SOARES, MARIA CARMO MIGUEIS, DIOGO DE PAIVA

WY: Outpatient weekly neoadjuvant paring neoadiuvant chemotherapy plus
chemotherapy followed by radiotherapy radiotherapy with radiotherapy alone in
bf advanced nosopharyngeol carcino- patients with Iocoregionally advanced
ma: high complete response and low toxi— nasopharyngeal carcinoma.
city rates: British Journal of Cancer, 2003, J Clin Oncol 20: 2038-2044, 2002.
88, 187-194 16 Rossi A, Molinari R, Borocchi P, et al: Ad-
14 Lin JC, Jon JS, Hsu CY, liong WM, Jiang iuvam chemotherapy with vincristine, cy-
RS, Wang WY: Phase III study os concur- clophosphamide, and doxorubicin after
rent chemoradiolheropy versus radiothe- radiotherapy in Iocal-regional nasopha-
rapy alone for advanced nasopharynge- ryngeol cancer: Results of o 4-year multi-
01 carcinoma: positive effect on overall center randomized study. J Clin Oncol ó:
and progression—Íree survival: Journal of 140-1410, 1988.
clinical oncology, vol 21, n 4, 2003: 17 Zhang EP, lion PG, Cai Kl, et al: Radia-
pp631-637, DOI: 10. 1200/.ICO. tion therapy of nosopharyngeol carcino
2003.06.158 ma: Prognostic factors based on a 10-
15 Ma J, Mai HQ, Hong MH, et al: Results -yeor Íollow-up of 1032 patients. Int] Ra-
of a progressive randomized trial com- diot Oncol Biol Phys 23: 261-270, 1992